GPs mainly provide exercise advice if it will help reduce the health complaint General Practitioners (GPs) mainly give their patients advice to engage in physical activity when exercise can reduce health complaints.
Nearly one-quarter of the Dutch population suffers from complaints or disorders of the digestive system Nearly 1 in 4 people in the Netherlands were registered at their general practitioner in 2017 with stomach, bowel or liver problems. This involves more than 3.7 million people.
Updated immunisation recommendation for measles: early vaccination before travel A number of European countries are currently seeing outbreaks of measles. Before the start of the summer season, RIVM has therefore updated its immunisation recommendation for measles.
Longest ever recorded flu epidemic measured in 2015 The most notable infectious disease outbreak in 2015 was the flu epidemic in the winter of 2014-2015, which at 21 weeks was the longest ever recorded in the Netherlands.
First patient infected by tick-borne encephalitis virus For the first time, a person in the Netherlands has fallen ill after a bite from a tick carrying the tick-borne encephalitis virus (TBE virus).
Livestock farming affects pulmonary function in local residents COPD patients living near livestock farms suffer more complications.
Nicoline Tamsma re-elected as EuroHealthNet president Nicoline Tamsma has been elected to serve a new two-year term as EuroHealthNet president. EuroHealthNet is a European network organisation of public health and health promotion institutes.
RIVM and German BfR enter cooperation agreement on animal protection and food safety The German Federal Institute of Risk Assessment (BfR) and the Dutch National Institute for Public Health and the Environment, RIVM have signed a cooperation agreement, focused on developing new sci
Bacteria slightly more often resistant to last resort antibiotics Antimicrobial resistance is a global problem. In the Netherlands, some bacteria that can cause infections in people are more frequently resistant to antibiotics used as a last resort.
RIVM to research safe design for new nanoparticles RIVM will be working alongside a consortium of 23 international partners on a safe design for ‘new’ nanoparticles.